Hexavest’s Quest Diagnostics DGX Stock Holding History

Hexavest’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-191,181	Closed	-$15.4M	–	414
2020 Q1	$15.4M	Sell	191,181 -956	-0.5%	-$99K	0.27%	111
2019 Q4	$20.5M	Buy	+192,137	New	+$20M	0.25%	121

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hexavest's DGX Position: Q2 2020 in Review

Hexavest sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 191,181 shares — an estimated $15.4M sold.

Hexavest first reported a position in DGX in Q4 2019 and held it in 2 quarters. The position peaked at $20.5M in Q4 2019. 748 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

Hexavest reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
Hexavest sold 191,181 Quest Diagnostics shares in Q2 2020, an estimated $15.4M.
Hexavest first reported a position in Quest Diagnostics in Q4 2019 and held it in 2 quarters.
Hexavest's Quest Diagnostics position peaked at $20.5M in Q4 2019.
748 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Hexavest's 13F filing for Q2 2020, filed 10 Jul 2020.